Evaluation of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Adults Aged 65 Years and Older: A Self-Controlled Study in the U.S
Preprint in medRxiv (January 2023)
The most recent citing publications are shown below. View all 166 publications that cite this research output on Dimensions.
Adverse events following first and second dose COVID-19 vaccination in England, October 2020 to September 2021: a national vaccine surveillance platform self-controlled case series study.
Article in Eurosurveillance (January 2023)
Background rate estimations for thrombosis with thrombocytopaenia: challenges in evaluating rare safety signals following vaccination in real time during a pandemic
Article in BMJ Open (January 2023)